Mengjun Wang
No. 67 West Dongchang Road
Liaocheng, 252000, China
Liaocheng, 252000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Engineered PD1-NKG2D Dual-CAR NK92 cells broaden antitumor target recognition in preclinical tumor models.
Journal: Journal of translational medicine
Published: April 13, 2026
USP39 deubiquitinase: Dual roles in RNA splicing and protein stabilization in cancer therapeutics.
Journal: International journal of biological macromolecules
Published: October 03, 2025
Corrigendum to "Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability" [Eur. J. Pharm. Biopharm. 213 (2025) 114756].
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: June 08, 2025
STING agonists: a range of eminent mediators in cancer immunotherapy.
Journal: Cellular signalling
Published: May 07, 2025
Preparation and evaluation of celecoxib lyophilized orally disintegrating tablets with high bioavailability.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: March 18, 2025
The pivotal role of CRIHSP sequences in orchestrating antigen receptor diversity and genomic stability within antigen receptor germline genes.
Journal: International journal of biological macromolecules
Published: October 25, 2024
New Insights into Mitochondria in Health and Diseases.
Journal: International journal of molecular sciences
Published: August 28, 2024
METTL protein family: focusing on the occurrence, progression and treatment of cancer.
Journal: Biomarker research
Published: July 17, 2024
Challenges in the Development of NK-92 Cells as an Effective Universal Off-the-Shelf Cellular Therapeutic.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: March 29, 2024
USP32 facilitates non-small cell lung cancer progression via deubiquitinating BAG3 and activating RAF-MEK-ERK signaling pathway.
Journal: Oncogenesis
Published: March 06, 2024
Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
Journal: Journal of translational medicine
Published: July 10, 2023
USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target.
Journal: Cell death discovery
Published: June 09, 2023
Last Updated: 09/26/2026